A global survey of companies pursuing 'nanomedicine' indicates that nanotechnology is taking root in the drug and medical device industry. This article presents data from the above study showing ...

Academic participation in nanomedicine research is welcomed by European industries. The recipe for success may or may not include creativity, but it will certainly require awareness of drug ...

We recommend that you apply as early as possible. We reserve the right to close applications if the course is full. Understand the role of nanomedicine within healthcare innovation, particularly ...

Nanomedicine holds immense promise for revolutionizing healthcare. By manipulating materials at the nanoscale, researchers ...

Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...

We recommend that you apply as early as possible. We reserve the right to close applications if the course is full. Understand the role of nanomedicine within healthcare innovation, particularly ...

Nanomedicines save lives, but they don't reach the market or the patient's body fast enough. Researchers have now come up with a recipe to accelerate and improve the process.

Researchers developed a coordination nanomedicine (ZnDHT NM) that targets tumor cells and cancer stem-like cells, enhancing cancer treatment efficacy.

The following is a summary of "Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines," ...

which is highly encouraging for cancer nanomedicine design and future tumor therapeutics,” Yufang Zhu says.

Dr. Daniel A. Heller, PhD, is Head of the Cancer Nanomedicine Laboratory, a Member in the Molecular Pharmacology Program at Memorial Sloan-Kettering Cancer Center, and a Professor in the Department of ...